Tegretol

Basic Tegretol information

• INN (international nonproprietary name): Carbamazepine.
• Brand names available in the United Kingdom: Tegretol; Tegretol Retard.
• ATC code: N03AF01.
• Forms and strengths: tablets 100 mg, 200 mg and 400 mg; Retard (prolonged‑release) tablets 200 mg and 400 mg; oral liquid 100 mg/5 mL; no injectable formulations for routine use.
• Manufacturers in the United Kingdom: Originator Novartis and multiple generics from Teva, Sandoz, Mylan, Zentiva, Stada, Egis and Adamed.
• Registration status in the United Kingdom: Approved by the MHRA and available on prescription.
• OTC / Rx classification: Prescription‑only.

Legal status and availability in the UK

In our online pharmacy, Tegretol is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Clinical effectiveness in the UK

Want to know how people in the NHS actually do on Tegretol?

Many patients with focal epilepsy achieve good seizure control once therapeutic levels are reached.

Slow titration and pharmacist follow‑up help patients stay on treatment.

Adherence challenges in community prescribing are commonly linked to early dizziness, sedation and the need for stepwise titration.

Common adverse effects are dizziness, sedation and mild rash; laboratory abnormalities are monitored routinely.

Monitoring practice across many NHS trusts includes baseline FBC, LFTs and serum sodium at initiation and after dose changes.

Indications and expanded uses

Is Tegretol right for my condition?

MHRA‑approved uses include partial (focal) seizures, generalised tonic–clonic seizures and trigeminal neuralgia.

Carbamazepine is also licensed for prophylaxis of bipolar disorder in patients unresponsive to lithium; other uses, such as acute mania when valproate is unsuitable and some neuropathic pain states, are off‑label specialist practice.

• MHRA‑approved: Epilepsy (partial and generalised tonic–clonic), trigeminal and glossopharyngeal neuralgia, and prophylaxis of bipolar disorder unresponsive to lithium.
• Off‑label / specialist: Acute mania in select cases and certain neuropathic pain presentations.

GPs should document off‑label discussions and monitor response carefully when a specialist recommends carbamazepine.

Patients moving between NHS and private clinics benefit from carrying clear records of indications and monitoring plans.

Composition and brand landscape

Which brand will I pick up from the pharmacy?

Carbamazepine is available as Tegretol and Tegretol Retard in the United Kingdom alongside multiple generics supplied by major manufacturers such as Teva, Sandoz, Mylan and Zentiva.

For epilepsy, the MHRA advises that patients taking carbamazepine should be kept on a specific manufacturer’s product, so switching between brands is avoided; contact the prescriber if any issues arise after a change.

Contraindications and special precautions

Who should not take Tegretol?

• Absolute contraindications: Known allergy to carbamazepine or tricyclic compounds, history of bone‑marrow depression, prior Stevens–Johnson syndrome/TEN due to carbamazepine, and concomitant MAOI use.
• Relative cautions: Moderate–severe liver or renal impairment, cardiac conduction disorders, elderly patients (higher hyponatraemia risk), pregnancy unless no alternative and history of blood dyscrasias.

Patients of Han Chinese or Thai origin should be considered for HLA‑B*1502 genetic risk assessment where clinically appropriate, as part of risk minimisation for SJS/TEN.

Lifestyle restrictions include avoiding heavy alcohol during initiation and titration and exercising caution when driving until stability is confirmed.

Pharmacists should counsel on pregnancy planning and the need to report any new rash immediately.

Dosage guidelines

How should I take Tegretol for epilepsy or nerve pain?

Retard or sustained‑release formulations must not be split.

Missed dose advice: take as soon as remembered unless near the next dose and never double up.

Dose adjustments are required in hepatic impairment and when interacting drugs are present; consider therapeutic drug monitoring in complex cases.

Interactions overview

Will Tegretol affect my other medicines?

Carbamazepine is a potent inducer of multiple CYP enzymes, especially CYP3A4, and causes many clinically significant interactions.

Major interactions include reduced efficacy of hormonal contraception, lowered plasma levels of some anticoagulants and direct oral anticoagulants, and altered levels of antipsychotics and antidepressants.

CYP inhibitors such as azole antifungals and certain macrolide antibiotics can raise carbamazepine levels and increase toxicity risk.

Patients must tell prescribers and pharmacists about all medicines, including over‑the‑counter products and herbal preparations such as St John’s wort.

Interaction‑related adverse effects can be serious, so monitoring and counselling are essential; report suspected side effects via the Yellow Card scheme.

Comparable medicines and preferences

Are there better options for my condition?

NHS guidance lists several alternatives to carbamazepine depending on the clinical context.

Choice on the NHS is stratified by sex, pregnancy potential, comorbidity and concomitant medicines, and specialist review is common when switching between agents.

Frequently asked questions

Can I drive on Tegretol?

Avoid driving while experiencing dizziness or impaired consciousness.

Notify the DVLA and your insurer if you have a seizure or persistent side‑effects that affect alertness.

Is carbamazepine safe in pregnancy?

Carbamazepine carries teratogenic risk and should be reviewed with a specialist before conception.

What if I miss a dose?

Take as soon as you remember unless it is near the next dose; do not double up.

Can I stop suddenly?

No; withdrawal should be gradual under medical supervision to avoid seizure recurrence.

Will the pharmacy switch brands?

For epilepsy, the MHRA advises keeping patients on the same manufacturer’s product, so prescriptions usually specify the brand or manufacturer; ask your prescriber or pharmacist if your tablets look different.

Guidelines for proper use

What should pharmacists tell patients at the first dispense?

• Explain the indication and dosing schedule clearly, including how to take Retard versus immediate‑release tablets.
• Warn about early side‑effects such as dizziness and drowsiness, and instruct to report any rash immediately.
• Advise on contraception reliability and the need for additional methods while taking carbamazepine.
• Arrange baseline blood tests (FBC, LFTs, sodium) and a monitoring schedule with the GP or specialist.

Provide written information and confirm understanding at the first supply, using NHS repeat dispensing or electronic messaging to remind patients about laboratory follow‑up.

Storage advice: store at room temperature between 15–30°C in the original packaging and avoid splitting sustained‑release tablets.

Delivery across the United Kingdom

Final practical notes

Keep a record of the exact brand and batch you receive and report concerns to your pharmacist or prescriber.

Contact the MHRA Yellow Card scheme to report suspected adverse reactions.

When in doubt, ask for pharmacist counselling and request a follow‑up appointment with the GP or specialist for monitoring and dose review.